๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP ยท Real-Time Price ยท USD
2.380
-0.170 (-6.67%)
At close: Nov 20, 2026, 4:00 PM EST
2.370
-0.010 (-0.42%)
After-hours: Nov 20, 2026, 4:15 PM EST

TNXP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
43.0513.1110.097.77--
Revenue Growth
317.96%29.85%29.94%---
Gross Profit
38.466.472.333.03--
Operating Income
-187.79-125.7-77.74-118.38-112.09-92.31
Net Income
-180.99-124.02-130.04-116.66-116.88-92.29
Earnings Per Share
-11.93-14.57-176.60---
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
162.79207.6498.7824.95120.23178.66
Total Debt
1.251.318.129.810.760.96
Net Cash (Debt)
161.54206.3390.6615.14119.47177.7
Net Cash Growth
-14.81%127.59%498.99%-87.33%-32.77%134.57%
Net Cash Per Share
10.6524.24123.12---

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-165.29-99.84-60.93-102-98.05-75.56
Capital Expenditures
-4.76-3.37-0.12-7.9-48.15-35.31
Free Cash Flow
-170.04-103.21-61.05-109.9-146.2-110.86
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
89.33%49.34%23.07%38.97%--
Operating Margin
-436.25%-959.05%-770.20%-1523.94%--
Pretax Margin
-420.45%-946.22%-1288.25%-1501.78%--
Profit Margin
-420.45%-946.22%-1288.25%-1501.78%--
FCF Margin
-395.02%-787.47%-604.76%-1414.75%--

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.1514.776.113.04--